treatment with the aromatase inhibitor 4-oh-a caused a parallel decrease in plasma and tumor levels of pregnenolone ( preg ) , progesterone ( p ) , and 17-oh p , while there was a marked increase in dehydroepiandrosterone ( dhea ) , androst-5-ene-3 beta,17 beta-diol ( delta 5-diol ) , androstenedione ( delta 4-dione ) , testosterone ( t ) , androstane-3 alpha , 17 beta-diol ( 3 alpha-diol ) , and androstane-3 beta,17 beta-diol ( 3 beta-diol ) , with no significant change in dihydrotestosterone ( dht ) and 17 beta-estradiol levels .
C0039601
testosterone
C0002854
androstane